Ardent Health (ARDT) Common Equity (2023 - 2026)

Ardent Health's Common Equity history runs 4 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• In Q1 2026, Common Equity rose 10.88% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (up 10.88% YoY), while the FY2025 annual figure was $1.7 billion, up 10.85% from the prior year.
• Common Equity for Q1 2026 stood at $1.7 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Common Equity was $1.7 billion in Q1 2026, with the low at $1.1 billion in Q2 2023.
• The 4-year median for Common Equity is $1.5 billion (2024), against an average of $1.4 billion.
• The sharpest annual moves came in 2024 and 2025: Common Equity advanced 8.98% in 2024, then soared 42.2% in 2025.
• Ardent Health's Common Equity stood at $1.1 billion in 2023, then surged by 41.51% to $1.5 billion in 2024, then increased by 10.85% to $1.7 billion in 2025, then rose by 2.89% to $1.7 billion in 2026.
• Business Quant data shows ARDT's Common Equity at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.6 billion in Q3 2025.